-
Intense heat puts births in jeopardy, UN tells Fiji talks
-
Spain PM calls early election after housing crisis defeat
-
US arrests woman accused of spying for China on Taiwan leader's family
-
Stocks rally as 'Goldilocks' jobs data ease rate fears
-
Yemen military announces broad strikes against Houthis
-
Myanmar says 10,000 migrants returned from Malaysia this year
-
Zuckerberg skewered again on screen in 'The Social Reckoning'
-
Big guns back for Australia's Rugby League World Cup defence
-
Fiji urges 'just' climate transition, financing at pre-COP gathering
-
Braves rock Dodgers to level series, Brewers win thriller
-
Thailand's Jeeno overcomes late wobble to win Lotte Championship
-
Most Asia stocks rally as 'Goldilocks' jobs data ease rate fears
-
Brazil heads to run-off as Bolsonaro pulls off shock first place finish over Lula
-
Sunken Silk Road city reveals Central Asia's lost history
-
EU, China to hold Beijing talks to avert trade war
-
Three years on, Israeli rescuer cannot escape October 7
-
Bolsonaro edges past Lula as nail-biter Brazil vote goes to a run-off
-
Research into weight-loss drugs tipped for Nobel as award week opens
-
Rubio visits Iceland as US boosts Arctic presence
-
US Supreme Court hears bid to shut the door on climate suits
-
Bolsonaro leads Lula as nail-biter Brazil vote goes to a run-off
-
Chourio walk-off single lifts Brewers over Padres
-
Patriots inflict first Bills defeat as Chiefs keep winning
-
Eagle Plains' Partner Xcite Uranium Commences Drill Program at the Black Bay Project, Adds Second Drill, Uranium City, Saskatchewan
-
Argo to Present at National Investment Banking Association's (NIBA) 153rd Investment Conference in Fort Lauderdale
-
Apex Extends Trinity Zone 200 m with 3.55% REO over 116.0 m and 2.35% over 171.5 m in Western Step-out Drilling at Rift
-
Genflow Biosciences PLC Announces Presentation of Interim Results
-
Fulcrum Metals PLC Announces Pilot site & Pilot Technology Agreement Secured
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 05
-
Flavio Bolsonaro leads Lula in near-done Brazil vote count
-
Pacific nations take centre stage at 'pre-COP' climate summit
-
Flavio Bolsonaro leads Lula in partial Brazil poll results
-
Ronaldo can return to Portugal team if he wants: coach Jesus
-
Titan FX Launches Second “Dream Beyond Borders 2.0” Brand Commercial Featuring Keisuke Honda
-
Portugal move into Nations League knockout stage, Germany held
-
Patriots inflict first Bills defeat as Rams surge late
-
Ronaldo-less Portugal beat Norway to reach Nations League quarters
-
Brazil's Indigenous back Lula as El Nino fuels forest fires
-
Bosnian Serb strongman claims election win, thanks Trump and Putin
-
Brazil braces for results of election battle between Lula and Bolsonaro
-
Israel wear black armbands in Ireland tie over Hamas attack
-
Indians protest election chief ahead of top court hearing
-
'I fear it could drag on': anxiety takes hold in Ethiopian city wrested from rebels
-
'Verity' kills, Cruise bombs in N. American movie theaters
-
Brazil's Lula and Flavio Bolsonaro face off in knife-edge election
-
Colts top Commanders in NFL London game
-
UK Green party adopts 'Zionism is racism' policy
-
Hundreds of schools to shut Monday as student protests rock France
-
Rio favela residents vote with little hope
-
Three previous two-time Arc de Triomphe winners
Warmer noses are better at fighting colds: study
Chilly weather and common respiratory infections often go hand in hand.
Reasons for this include people gather inside more in winter, and viruses survive better in low-humidity indoor air. But there has been less certainty about whether lower temperatures actually impair human immunity and, if so, how.
Now, a new study published Tuesday in The Journal of Allergy and Clinical Immunology details a previously unknown way that the immune system attacks viral intruders inside the nose -- and finds it works better when it's warm.
These discoveries could pave the way for an eventual treatment against the common cold and other viruses, Mansoor Amiji, a pharmaceutical sciences professor at Northeastern University, who co-led the research, told AFP.
The starting point was previous research by Amiji and colleagues in 2018, which found that nasal cells released "extracellular vesicles" (EVs) —- a spray of tiny sacs that swarmed and destroyed bacteria upon inhalation.
"The best analogy that we have is a hornet's nest," said Amiji. Like hornets defending a nest from attack, EVs swarm, bind to, and kill invaders.
For the new research, the team set out to answer two questions: are EVs also secreted in the nose in the presence of viral infections? And, if they are, is the strength of their response linked to temperature?
To answer the first question, they used a test substance which mimics a viral infection to stimulate nasal mucosa -- a thin tissue that lines the nose -- that was taken from volunteers who had surgery to remove polyps.
They found it did in fact produce EVs that target viruses.
In order to tackle the second question, they divided the nasal cell samples into two groups and cultured them in a lab, subjecting one set of samples to 37 degrees Celsius, and the other to 32C.
These temperatures were chosen based on a separate test that found the temperature inside the nose falls by about 5C when outside air drops from 23C to 4C.
Under regular body heat conditions, the EVs were successfully able to fight off viruses, by presenting them with "decoy" targets that they latch on to instead of the receptors they would otherwise target on cells.
But under the reduced temperatures, fewer EVs were produced, and those that were made packed less punch against the invaders tested: two rhinoviruses and a non-Covid coronavirus, which are typically found in winter cold season.
"There's never been a convincing reason why you have this very clear increase in viral infectivity in the cold months," said co-author Benjamin Bleier, a surgeon at Harvard Medical School and Massachusetts Eye and Ear, in a statement.
"This is the first quantitative and biologically plausible explanation that has been developed."
One of the most exciting aspects of the work is the potential to rev up the body's natural production of virus-targeting EVs in order to fight or even fend off the cold -- or even the flu and Covid, said Amiji.
"That's an area of great interest for us and we certainly continue to pursue that," he said.
D.Cunningha--AMWN